On March 9, 2026, Abbott Laboratories raised $20 billion by issuing senior notes of various types to finance its acquisition of Exact Sciences Corporation and for general corporate needs. The notes include amounts due between 2029 and 2066 with fixed and floating interest rates ranging from 3.700% to 5.600%.